Here's the live share price of Hester Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Hester Biosciences | 14.60 | 29.66 | 74.51 | 63.90 | 40.04 | 13.77 | 0.16 |
| Sun Pharmaceutical Industries | 1.29 | 7.52 | 16.78 | 11.08 | 15.35 | 21.61 | 23.58 |
| Divi's Laboratories | 1.56 | 3.23 | 13.08 | 5.82 | 0.48 | 23.56 | 8.40 |
| Torrent Pharmaceuticals | 3.80 | 8.24 | 18.37 | 25.29 | 49.30 | 36.55 | 26.83 |
| Cipla | -2.12 | 3.22 | 17.85 | -2.63 | -3.87 | 11.60 | 8.28 |
| Zydus Lifesciences | -0.58 | 2.60 | 22.89 | 26.75 | 15.80 | 24.67 | 11.92 |
| Lupin | 0.71 | 9.66 | 7.84 | 13.88 | 31.75 | 39.79 | 16.70 |
| Mankind Pharma | -0.56 | 6.12 | 21.04 | 13.02 | -2.37 | 13.26 | 12.06 |
| Dr. Reddy's Laboratories | -10.55 | -3.57 | -0.46 | 1.14 | -1.95 | 5.98 | 2.29 |
| Aurobindo Pharma | -4.21 | 6.00 | 15.84 | 32.34 | 38.01 | 28.23 | 10.54 |
| Laurus Labs | 1.17 | 12.18 | 43.37 | 49.65 | 97.18 | 63.59 | 18.17 |
| Alkem Laboratories | -0.20 | 4.87 | 3.74 | -5.26 | 15.66 | 16.56 | 10.62 |
| Biocon | -5.09 | -2.94 | 17.28 | 8.74 | 8.28 | 16.85 | 0.87 |
| Glenmark Pharmaceuticals | 4.28 | 7.47 | 5.03 | 14.18 | 5.63 | 50.90 | 28.57 |
| Abbott India | 5.85 | 4.95 | 6.37 | -3.70 | -20.48 | 4.95 | 9.62 |
| Ipca Laboratories | 2.92 | 13.63 | 26.34 | 19.93 | 26.47 | 33.78 | 11.62 |
| Ajanta Pharma | 2.55 | 8.62 | 17.78 | 24.75 | 29.78 | 34.57 | 18.86 |
| Anthem Biosciences | -2.56 | -3.83 | 2.77 | 21.44 | 2.69 | 0.89 | 0.53 |
| GlaxoSmithKline Pharmaceuticals | 1.06 | 15.00 | 0.34 | 0.81 | -25.42 | 20.29 | 10.07 |
| Gland Pharma | 0.29 | 7.03 | 43.32 | 44.88 | 32.73 | 30.66 | -7.29 |
Source: Dion Global
Over the last one year, Hester Biosciences has gained 40.04% compared to peers like Sun Pharmaceutical Industries (15.35%), Divi's Laboratories (0.48%), Torrent Pharmaceuticals (49.30%). From a 5 year perspective, Hester Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (23.58%) and Divi's Laboratories (8.40%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,152.01 | 2,126.38 |
| 10 | 2,173.57 | 2,138.06 |
| 20 | 2,121.4 | 2,110.01 |
| 50 | 1,945.93 | 1,967.03 |
| 100 | 1,709.76 | 1,828.16 |
| 200 | 1,679.82 | 1,767.46 |
Source: Dion Global
In the latest quarter, Hester Biosciences remained same as its previous close in promoter holding, while DII stake decreased to 0.00%, FII holding fell to 0.38%, and public shareholding moved up to 45.88% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Jul 09, 2026, 10:05 PM IST IST | Hester Biosciences - Disclosure Under Regulation 30 Of The SEBI Listing Regulations- Sale Of Equity Investment In Texas Lifes |
| Jul 08, 2026, 05:59 AM IST IST | Hester Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jul 08, 2026, 05:55 AM IST IST | Hester Biosciences - Corrigendum To The Notice Convening 39Th Annual General Meeting |
| Jun 18, 2026, 08:51 PM IST IST | Hester Biosciences - Business Responsibility and Sustainability Reporting (BRSR) |
| Jun 18, 2026, 08:36 PM IST IST | Hester Biosciences - Intimation Of Record Date For Dividend And Meeting |
Source: Dion Global
Hester Biosciences Ltd. is a Public Limited Listed company incorporated on 29/04/1987 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L99999GJ1987PLC022333 and registration number is 022333. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 292.14 Cr. and Equity Capital is Rs. 8.51 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Hester Biosciences is ₹2,531.25 as on Jul 13, 2026.
The Hester Biosciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Hester Biosciences is ₹2,153.30 Cr as on Jul 13, 2026.
Today’s highest and lowest price of Hester Biosciences are ₹2,531.25 and ₹2,109.40.
The 52-week high/low is the highest and lowest price at which Hester Biosciences stock has traded in the past 52-week or nearly a year. The 52-week high of Hester Biosciences is ₹2,347.70 and 52-week low of Hester Biosciences is ₹1,250.95 as on Jul 13, 2026.
The Hester Biosciences has shown returns of 20.0% over the past day, 29.66% for the past month, 74.51% over 3 months, 40.04% over 1 year, 13.77% across 3 years, and 0.16% over 5 years.
P/E ratio of and PB ratio of Hester Biosciences are 38.70 and 5.98 on Jul 13, 2026. While the company gives a dividend yield of 0.43 per annum.
Source: Dion Global